JPS6354690B2 - - Google Patents

Info

Publication number
JPS6354690B2
JPS6354690B2 JP61184973A JP18497386A JPS6354690B2 JP S6354690 B2 JPS6354690 B2 JP S6354690B2 JP 61184973 A JP61184973 A JP 61184973A JP 18497386 A JP18497386 A JP 18497386A JP S6354690 B2 JPS6354690 B2 JP S6354690B2
Authority
JP
Japan
Prior art keywords
coenzyme
heart
agent according
muscle metabolism
muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61184973A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6253924A (ja
Inventor
Buratsusei Pieeruunoeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZOIREFU AG
Original Assignee
ZOIREFU AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZOIREFU AG filed Critical ZOIREFU AG
Publication of JPS6253924A publication Critical patent/JPS6253924A/ja
Publication of JPS6354690B2 publication Critical patent/JPS6354690B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP61184973A 1985-08-06 1986-08-05 心臓および筋代謝保護剤 Granted JPS6253924A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH3362/85A CH666183A5 (it) 1985-08-06 1985-08-06 Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare.
CH3362/85-1 1985-08-06

Publications (2)

Publication Number Publication Date
JPS6253924A JPS6253924A (ja) 1987-03-09
JPS6354690B2 true JPS6354690B2 (https=) 1988-10-28

Family

ID=4254335

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61184973A Granted JPS6253924A (ja) 1985-08-06 1986-08-05 心臓および筋代謝保護剤

Country Status (8)

Country Link
JP (1) JPS6253924A (https=)
BE (1) BE905210A (https=)
CH (1) CH666183A5 (https=)
DE (1) DE3625433A1 (https=)
FR (1) FR2586352B1 (https=)
GB (1) GB2178661B (https=)
IT (1) IT1213319B (https=)
NL (1) NL8601979A (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19537494C2 (de) * 1995-09-25 1997-10-02 Desitin Arzneimittel Gmbh Kreatin zum Schutz von neuralem Gewebe
WO2003002147A1 (en) * 2001-06-28 2003-01-09 Takeda Chemical Industries, Ltd. Preventives/remedies for organ functional disorders and organ dysfunction
DE202023001978U1 (de) 2023-09-20 2023-09-29 Penta Phi Eg Formulierung umfassend Coenzym Q10 und Kreatin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.

Also Published As

Publication number Publication date
GB2178661A (en) 1987-02-18
BE905210A (nl) 1986-12-01
DE3625433A1 (de) 1987-02-19
IT1213319B (it) 1989-12-20
FR2586352B1 (fr) 1992-05-29
JPS6253924A (ja) 1987-03-09
NL8601979A (nl) 1987-03-02
GB2178661B (en) 1989-08-31
GB8618589D0 (en) 1986-09-10
CH666183A5 (it) 1988-07-15
FR2586352A1 (fr) 1987-02-27
IT8621394A0 (it) 1986-08-01

Similar Documents

Publication Publication Date Title
DE3855120T2 (de) The use of AICA riboside or AICA ribotide for the preparation of a medicament against heart attack or stroke in patients with atherosclerosis
EP0786993B1 (en) Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and their use in the treatment of metabolic and cardiovascular disorders
US4978668A (en) Treatment to reduce ischemic tissue injury
JP2010510973A (ja) 心筋組織の壊死を処置するためのホスホエノールピルビン酸誘導体の使用
JPH02191221A (ja) イノシトールトリホスフェートを含有する移植に関する障害に対する医薬
AU782367B2 (en) Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose
EP1121930B1 (en) Drug preparation "histochrome" for treating acute myocardial infarction and ischaemic heart diseases
JP3622985B2 (ja) マグネシウム吸収を高め、アテローム性動脈硬化症を防ぐ方法
EP0199117A2 (en) New therapeutical use of phosphocreatine
JPS6354690B2 (https=)
RU2096034C1 (ru) Фармацевтическая композиция, индуцирующая биосинтез глутатиона, активность глутатионтрансферазы и оказывающая антитоксическое, радиопротекторное и антигипоксическое действие, и способы лечения, профилактики и защиты с ее использованием
EP0530220B1 (en) Pharmaceutical composition
RU2045961C1 (ru) Способ проведения коронарографии в эксперименте
US20050182136A1 (en) N-acetylcysteine compositions and methods for the treatment and prevention of endothelial dysfunction
JPH0380771B2 (https=)
Mittra Use of potassium, glucose and insulin in the treatment of myocardial infarction
EP0140958B1 (en) Oncolytic drug combinations
US20100016244A1 (en) D-glucopyranose 1-[3,5-bis (1,1-dimethylethy)-4-hydroxybenzoate] and its derivatives, preparation and use thereof
KR0159949B1 (ko) 허혈-재관류 조직 장해, 부정맥, 및 활성산소 및 자유 라디칼에 의해 야기된 폐장해의 예방 또는 치료제
RU2292885C2 (ru) Антиаритмическое лекарственное средство "тиодарон"
JPH0526766B2 (https=)
WO2015012779A1 (ru) Лекарственное средство кардиопротекторного действия
RU2148999C1 (ru) Применение этимизола в качестве антиаритмического средства для предупреждения желудочковой экстрасистолии у больных ибс
WO2023218364A1 (en) Anti-aging and anti-inflammatory compositions comprising nicotinamide mononucleotide and reservatrol and uses thereof
RU2627458C1 (ru) Способ коррекции процессов перекисного окисления липидов у больных острым инфарктом миокарда